Last updated: August 17, 2026
Borreliosis diagnostics is often based on the clinical appearance together with anamnesis and the evidence of specific antibodies.
Fundamentally, a positive Borrelia antibody test is separately no indicator for a therapy or reflects the clinical manifestations. In this case, detection of Borrelia-specific effector T-cells can provide further diagnostic assistance.
The AID LymeSpot Kit detects and measures the Interferon-y expression of Borrelia-specific effector T-cells
Scientific Case Review
Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?
Send your question to our scientific team. The NBScience head office in the United Kingdom coordinates inquiries across international network of medical centres, scientists, and specialised consultants.
- Review of the information you provide
- Relevant research and clinical program information
- A clear response focused on your situation
No obligation. Your question will be reviewed confidentially.
Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.
